開示日時:2022/06/06 16:00:00
損益
決算期 | 売上高 | 営業益 | 経常益 | EPS |
2018.03 | 110,742,900 | 9,923,200 | 8,951,800 | 133.58 |
2019.03 | 114,271,300 | 9,568,700 | 8,464,200 | 141.64 |
2020.03 | 112,925,400 | 8,776,900 | 7,930,000 | 128.23 |
2021.03 | 105,656,000 | 6,730,100 | 5,536,200 | 91.92 |
※金額の単位は[万円]
株価
前日終値 | 50日平均 | 200日平均 | 実績PER | 予想PER |
1,962.0 | 1,928.84 | 1,927.23 | 34.87 | 12.43 |
※金額の単位は[円]
キャッシュフロー
決算期 | フリーCF | 営業CF |
2018.03 | 3,253,500 | 8,227,200 |
2019.03 | 1,902,000 | 8,521,300 |
2020.03 | 3,542,000 | 9,264,700 |
2021.03 | 1,320,400 | 7,527,100 |
※金額の単位は[万円]
▼テキスト箇所の抽出
SEKISUI CHEMICAL CO., LTD. June 6, 2022 Announcement Concerning Status and Completion of Acquisition of Treasury Shares SEKISUI CHEMICAL CO., LTD., based on the applicable provisions Corporate Law Article 156 superseded by Article 165, paragraph 3 of the same law concerning the acquisition of treasury shares, is announcing that it implemented market buying as follows. Moreover, the acquisition of treasury shares based on the resolution of the Board of Directors meeting held on April 27, 2022 has been completed. Press Release (Reference) 1. Type of shares to be acquired: Common shares of SEKISUI CHEMICAL 2. Total number of shares acquired: 1,211,300 shares 3. Total cost of the acquisition: 2,281,796,300 yen 4. Acquisition period: From June 1, 2022 to June 6, 2022 5. Acquisition method: Market buying on the Tokyo Stock Exchange 1. Details of the resolution of the Board of Directors meeting held on April 27, 2022 • Type of shares to be acquired: Common shares of SEKISUI CHEMICAL • Total number of shares to be acquired: Up to 8,000,000 shares (maximum) (Percentage of total number of issued shares (excluding treasury stock): 1.80%) • Total acquisition cost: Up to 16 billion yen (maximum) • Acquisition period: From April 28, 2022 to March 31, 2023 2. Status of the acquisition as of June 6, 2022 • Total number of shares acquired: 8,000,000 shares • Total amount of acquisition cost: 14,071,670,800 yen Press Contact SEKISUI CHEMICAL CO., LTD. Public Relations Department Fax: (+81) 3-6748-6547